Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SIROCO: Simvastatin and Rosiglitazone in Metabolic Syndrome
NCT00831129Phase 3Completed
- Sponsor
- University of Chicago
- Start
- Sep 2006
- Primary completion
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rosiglitazone in metabolic syndrome, sponsored by University of Chicago. Started Sep 2006; status: completed.
02
Drugs
rosiglitazone
03
Conditions
metabolic syndrome
Beyond the preview
Go deeper on NCT00831129.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00831129.